Cargando…

Quantitative whole-brain 3D imaging of tyrosine hydroxylase-labeled neuron architecture in the mouse MPTP model of Parkinson's disease

Parkinson's disease (PD) is a basal ganglia movement disorder characterized by progressive degeneration of the nigrostriatal dopaminergic system. Immunohistochemical methods have been widely used for characterization of dopaminergic neuronal injury in animal models of PD, including the MPTP (1-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roostalu, Urmas, Salinas, Casper B. G., Thorbek, Ditte D., Skytte, Jacob L., Fabricius, Katrine, Barkholt, Pernille, John, Linu M., Jurtz, Vanessa Isabell, Knudsen, Lotte Bjerre, Jelsing, Jacob, Vrang, Niels, Hansen, Henrik H., Hecksher-Sørensen, Jacob
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Company of Biologists Ltd 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899010/ https://www.ncbi.nlm.nih.gov/pubmed/31704726 http://dx.doi.org/10.1242/dmm.042200

Ejemplares similares

Whole-brain activation signatures of weight-lowering drugs
por: Hansen, Henrik H., et al.
Publicado: (2021)

3D quantification of changes in pancreatic islets in mouse models of diabetes type I and II
por: Roostalu, Urmas, et al.
Publicado: (2020)

An Optimized Mouse Brain Atlas for Automated Mapping and Quantification of Neuronal Activity Using iDISCO+ and Light Sheet Fluorescence Microscopy
por: Perens, Johanna, et al.
Publicado: (2020)

Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer’s Disease
por: Hansen, Henrik H., et al.
Publicado: (2016)

The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer’s Disease
por: Hansen, Henrik H., et al.
Publicado: (2015)

Application of the Physical Disector Principle for Quantification of Dopaminergic Neuronal Loss in a Rat 6-Hydroxydopamine Nigral Lesion Model of Parkinson's Disease
por: Fabricius, Katrine, et al.
Publicado: (2017)

Effect of captopril on post-infarction remodelling visualized by light sheet microscopy and echocardiography
por: Roostalu, Urmas, et al.
Publicado: (2021)

Deep learning reveals 3D atherosclerotic plaque distribution and composition
por: Jurtz, Vanessa Isabell, et al.
Publicado: (2020)

Whole-brain three-dimensional imaging for quantification of drug targets and treatment effects in mouse models of neurodegenerative diseases
por: Hansen, Henrik H., et al.
Publicado: (2020)

Alterations in hypothalamic gene expression following Roux-en-Y gastric bypass
por: Barkholt, Pernille, et al.
Publicado: (2016)

A Hamster Model of Diet-Induced Obesity for Preclinical Evaluation of Anti-Obesity, Anti-Diabetic and Lipid Modulating Agents
por: Dalbøge, Louise S., et al.
Publicado: (2015)

Long‐acting glucagon‐like peptide‐1 receptor agonists have direct access to and effects on pro‐opiomelanocortin/cocaine‐ and amphetamine‐stimulated transcript neurons in the mouse hypothalamus
por: Knudsen, Lotte Bjerre, et al.
Publicado: (2016)

Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice
por: Madsen, Mette Simone Aae, et al.
Publicado: (2019)

The endogenous preproglucagon system is not essential for gut growth homeostasis in mice
por: Wismann, Pernille, et al.
Publicado: (2017)

Lipidated PrRP31 metabolites are long acting dual GPR10 and NPFF2 receptor agonists with potent body weight lowering effect
por: Alexopoulou, Flora, et al.
Publicado: (2022)

Peptide-YY(3-36)/glucagon-like peptide-1 combination treatment of obese diabetic mice improves insulin sensitivity associated with recovered pancreatic β-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitries
por: Boland, Brandon B., et al.
Publicado: (2021)

Global transcriptome analysis of rat hypothalamic arcuate nucleus demonstrates reversal of hypothalamic gliosis following surgically and diet induced weight loss
por: Barkholt, Pernille, et al.
Publicado: (2019)

Integrated Brain Atlas for Unbiased Mapping of Nervous System Effects Following Liraglutide Treatment
por: Salinas, Casper Bo Gravesen, et al.
Publicado: (2018)

The IL-1β Receptor Antagonist SER140 Postpones the Onset of Diabetes in Female Nonobese Diabetic Mice
por: Cucak, Helena, et al.
Publicado: (2016)

The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE(−/−) and LDLr(−/−) Mice by a Mechanism That Includes Inflammatory Pathways
por: Rakipovski, Günaj, et al.
Publicado: (2018)

Comment on: Butler et al. A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 Therapies Safe? Diabetes Care 2013;36:2118–2125
por: Bjerre Knudsen, Lotte, et al.
Publicado: (2013)

Hypertrophy Dependent Doubling of L-Cells in Roux-en-Y Gastric Bypass Operated Rats
por: Hansen, Carl Frederik, et al.
Publicado: (2013)

Characterisation of Age-Dependent Beta Cell Dynamics in the Male db/db Mice
por: Dalbøge, Louise S., et al.
Publicado: (2013)

Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet‐induced obese and biopsy‐confirmed mouse model of NASH
por: Møllerhøj, Mathias B., et al.
Publicado: (2022)

Shuttling of the chaperones Unc45b and Hsp90a between the A band and the Z line of the myofibril
por: Etard, Christelle, et al.
Publicado: (2008)

Lack of Apobec2-related proteins causes a dystrophic muscle phenotype in zebrafish embryos
por: Etard, Christelle, et al.
Publicado: (2010)

Allopregnanolone Reinstates Tyrosine Hydroxylase Immunoreactive Neurons and Motor Performance in an MPTP-Lesioned Mouse Model of Parkinson's Disease
por: Adeosun, Samuel O., et al.
Publicado: (2012)

Digital Brain Maps and Virtual Neuroscience: An Emerging Role for Light-Sheet Fluorescence Microscopy in Drug Development
por: Perens, Johanna, et al.
Publicado: (2022)

Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis
por: Tølbøl, Kirstine S, et al.
Publicado: (2018)

Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH
por: Baandrup Kristiansen, Maria Nicoline, et al.
Publicado: (2019)

Characterization of combined linagliptin and Y2R agonist treatment in diet-induced obese mice
por: Hansen, Henrik H., et al.
Publicado: (2021)

Disruptive influence
por: Cossu, Giulio, et al.
Publicado: (2013)

Neuroprotective effect of Rhodiola rosea Linn against MPTP induced cognitive impairment and oxidative stress
por: Jacob, Reenu, et al.
Publicado: (2013)

ApoE isoform-specific differences in behavior and cognition associated with subchronic MPTP exposure
por: Torres, Eileen Ruth S., et al.
Publicado: (2020)

Activation of the renal GLP‐1R leads to expression of Ren1 in the renal vascular tree
por: Bjørnholm, Katrine Dahl, et al.
Publicado: (2021)

The Discovery and Development of Liraglutide and Semaglutide
por: Knudsen, Lotte Bjerre, et al.
Publicado: (2019)

MCAM contributes to the establishment of cell autonomous polarity in myogenic and chondrogenic differentiation
por: Moreno-Fortuny, Artal, et al.
Publicado: (2017)

The MPTP Story
por: Langston, J. William
Publicado: (2017)

Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis
por: Ægidius, Helene M., et al.
Publicado: (2020)

Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD
por: Corti, Caspar, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nbl8dcmtnvvqrurce1c5ps6bkj